. Are phosphodiesterase Type 5 inhibitors potential therapies for Alzheimer's disease and related dementias?. Brain Commun. 2022;4(5):fcac260. Epub 2022 Oct 11 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.